Literature DB >> 8124718

An IL-4 receptor region containing an insulin receptor motif is important for IL-4-mediated IRS-1 phosphorylation and cell growth.

A D Keegan1, K Nelms, M White, L M Wang, J H Pierce, W E Paul.   

Abstract

Interleukin-4 (IL-4) treatment of 32D cells overexpressing insulin receptor substrate 1 (IRS-1) causes prompt tyrosine phosphorylation of IRS-1. Transfection of truncation mutants of the human IL-4 (huIL-4) receptor into 32D-IRS-1 cells demonstrated that the region from amino acid 437-557 is important for IL-4 signaling. This region of the IL-4 receptor (IL-4R) contains the motif 488PL-X4-NPXYXSXSD502 (insulin/IL-4R [I4R]) found in the insulin and insulin-like growth factor 1 receptors. Mutation of Y497 to F yielded receptors that caused little or no IRS-1 phosphorylation in response to huIL-4 when expressed in 32D-IRS-1 cells. Most cell lines expressing Y497F also failed to proliferate in response to huIL-4. Furthermore, a glutathione-S-transferase fusion protein containing the I4R motif-bound IRS-1, tyrosine kinase(s), and other unidentified phosphoproteins with molecular sizes of 140, 80, and 55 kd. Thus, the central tyrosine of the I4R motif has a major role in IL-4-mediated signal transduction in 32D cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8124718     DOI: 10.1016/0092-8674(94)90356-5

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  67 in total

Review 1.  Molecular mechanisms in T helper phenotype development.

Authors:  J D Farrar; S H Ranganath; K M Murphy
Journal:  Springer Semin Immunopathol       Date:  1999

Review 2.  IL-4 signaling, gene transcription regulation, and the control of effector T cells.

Authors:  M Boothby; A L Mora; M A Aronica; J Youn; J R Sheller; S Goenka; L Stephenson
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

3.  Identification of insulin receptor substrate 1 (IRS-1) and IRS-2 as signaling intermediates in the alpha6beta4 integrin-dependent activation of phosphoinositide 3-OH kinase and promotion of invasion.

Authors:  L M Shaw
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

Review 4.  Interleukin-4, interleukin-13, signal transducer and activator of transcription factor 6, and allergic asthma.

Authors:  Douglas A Kuperman; Robert P Schleimer
Journal:  Curr Mol Med       Date:  2008-08       Impact factor: 2.222

Review 5.  Integration of cytokine and heterologous receptor signaling pathways.

Authors:  Jelena S Bezbradica; Ruslan Medzhitov
Journal:  Nat Immunol       Date:  2009-03-19       Impact factor: 25.606

6.  Effects of common atopy-associated amino acid substitutions in the IL-4 receptor alpha chain on IL-4 induced phenotypes.

Authors:  Izolda Franjkovic; Andre Gessner; Inke König; Karin Kissel; Anette Bohnert; Anne Hartung; Astrid Ohly; Andreas Ziegler; Holger Hackstein; Gregor Bein
Journal:  Immunogenetics       Date:  2005-01-27       Impact factor: 2.846

Review 7.  Targeting insulin-like growth factor-I and insulin-like growth factor-binding protein-3 signaling pathways. A novel therapeutic approach for asthma.

Authors:  Hyun Lee; So Ri Kim; Youngman Oh; Seong Ho Cho; Robert P Schleimer; Yong Chul Lee
Journal:  Am J Respir Cell Mol Biol       Date:  2014-04       Impact factor: 6.914

8.  Interleukin 4 signals through two related pathways.

Authors:  A Pernis; B Witthuhn; A D Keegan; K Nelms; E Garfein; J N Ihle; W E Paul; J H Pierce; P Rothman
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

9.  Similarities and differences in signal transduction by interleukin 4 and interleukin 13: analysis of Janus kinase activation.

Authors:  A D Keegan; J A Johnston; P J Tortolani; L J McReynolds; C Kinzer; J J O'Shea; W E Paul
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

10.  Growth inhibition signalled through the interleukin-4/interleukin-13 receptor complex is associated with tyrosine phosphorylation of insulin receptor substrate-1.

Authors:  B Schnyder; H Lahm; G Woerly; N Odartchenko; B Ryffel; B D Car
Journal:  Biochem J       Date:  1996-05-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.